\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ palpable\\ nodule\\.\ \(0\)\
\-\ pth\\ \\ 420\\ pg\\/ml\\ \\(plasma\\)\\ nl\\ \\-\\ \\(7\\-62\\)\ \(0\)\
\-\ calcium\\ 11\\.1\\ mg\\/dl\\ \\(plasma\\)nl\\ \\-\\ \\(8\\.4\\ \\-\\ 10\\.2\\)\ \(0\)\
\-\ parathyroidectomy\ \(5\)\
\-\ 20\\ minute\\ early\\ \\(\\"thyroid\\ phase\\"\\)\\ images\\ demonstrate\\ normal\\ radiotracer\\ distribution\\ within\\ the\\ thyroid\\ gland\\,\\ as\\ well\\ as\\ questionably\\ increased\\ activity\\ over\\ the\\ lower\\ poles\\ of\\ the\\ thyroid\\ gland\\.\ \(1\)\
\-\ 2\\ hour\\ delayed\\ \\(\\"parathyroid\\ phase\\"\\)\\ images\\ demonstrate\\ decreased\\ activity\\ within\\ the\\ thyroid\\ gland\\.\\ \\ there\\ is\\ continued\\ probable\\ abnormal\\ focal\\ radiotracer\\ accumulation\\ over\\ the\\ lower\\ poles\\ of\\ both\\ lobes\\ of\\ the\\ thyroid\\ gland\\ versus\\ just\\ the\\ right\\ lobe\\.\\ \\ no\\ other\\ focal\\ abnormal\\ tracer\\ accumulation\\ is\\ identified\\.\ \(0\)\
\-\ right\\-sided\\ parathyroid\\ adenoma\\ \\(surgical\\)\ \(0\)\
\-\ parathyroid\\ adenoma\\(s\\)\ \(0\)\
\-\ parathyroid\\ hyperplasia\ \(5\)\
\-\ history\\ of\\ renal\\ transplant\\ with\\ chronic\\ hypercalcemia\\ and\\ hyperparathyroidism\\.\\ no\\ response\\ to\\ medical\\ management\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parathyroid\\:\\ 0\\.15039780673067618\ \(0\)\
\-\ thyroid\\:\\ 0\\.12160807100433024\ \(0\)\
\-\ gland\\:\\ 0\\.10109357476090747\ \(0\)\
\-\ poles\\:\\ 0\\.0808303632001737\ \(0\)\
\-\ plasma\\:\\ 0\\.08015272203115381\ \(0\)\
\-\ nl\\:\\ 0\\.07430253501620515\ \(0\)\
\-\ accumulation\\:\\ 0\\.06323386870729421\ \(0\)\
\-\ 420\\:\\ 0\\.05640535585698995\ \(0\)\
\-\ 7\\-62\\:\\ 0\\.05640535585698995\ \(0\)\
\-\ phase\\:\\ 0\\.05582955386624662\ \(0\)\
\-\ radiotracer\\:\\ 0\\.05537784287033607\ \(0\)\
\-\ questionably\\:\\ 0\\.05358962593957214\ \(0\)\
\-\ parathyroidectomy\\:\\ 0\\.05004222577453054\ \(0\)\
\-\ adenoma\\:\\ 0\\.04956242155286128\ \(0\)\
\-\ 11\\.1\\:\\ 0\\.048776103852350296\ \(0\)\
\-\ 10\\.2\\:\\ 0\\.04770561302021656\ \(0\)\
\-\ activity\\:\\ 0\\.04452842539974359\ \(0\)\
\-\ pg\\/ml\\:\\ 0\\.043406729628506675\ \(0\)\
\-\ 8\\.4\\:\\ 0\\.043406729628506675\ \(0\)\
\-\ pth\\:\\ 0\\.04041518160008685\ \(0\)\
\-\ \\(\\:\\ 0\\.040131207013547804\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.03975330535144571\ \(0\)\
\-\ \\)\\:\\ 0\\.03964098289518361\ \(0\)\
\-\ minute\\:\\ 0\\.03944461255581492\ \(0\)\
\-\ tracer\\:\\ 0\\.03886557360484928\ \(0\)\
\-\ \\-\\:\\ 0\\.038161009556424236\ \(0\)\
\-\ probable\\:\\ 0\\.03419234809622133\ \(0\)\
\-\ focal\\:\\ 0\\.033895744501922245\ \(0\)\
\-\ abnormal\\:\\ 0\\.0338485033377071\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.0333901752689863\ \(0\)\
\-\ transplant\\:\\ 0\\.032785929595447204\ \(0\)\
\-\ hour\\:\\ 0\\.03244710901093726\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.03114434085889005\ \(0\)\
\-\ over\\:\\ 0\\.030217258196388368\ \(0\)\
\-\ response\\:\\ 0\\.029742492575091956\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.0292385294304056\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.029168542189330793\ \(0\)\
\-\ calcium\\:\\ 0\\.029033259970394878\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.02896616336684115\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.028607631971975595\ \(0\)\
\-\ versus\\:\\ 0\\.028207834950417593\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02731183529629223\ \(0\)\
\-\ distribution\\:\\ 0\\.026706285586045122\ \(0\)\
\-\ lower\\:\\ 0\\.026692528741164758\ \(0\)\
\-\ lobes\\:\\ 0\\.02615043344942334\ \(0\)\
\-\ continued\\:\\ 0\\.025553611020251638\ \(0\)\
\-\ just\\:\\ 0\\.02478121077643064\ \(0\)\
\-\ nodule\\:\\ 0\\.024459816661402817\ \(0\)\
\-\ delayed\\:\\ 0\\.024152641279619306\ \(0\)\
\-\ images\\:\\ 0\\.02276755405485214\ \(0\)\
\-\ within\\:\\ 0\\.022640714005362245\ \(0\)\
\-\ management\\:\\ 0\\.02239257946844195\ \(0\)\
\-\ early\\:\\ 0\\.02170249284473915\ \(0\)\
\-\ 20\\:\\ 0\\.021336911362201498\ \(0\)\
\-\ identified\\:\\ 0\\.021204632230460565\ \(0\)\
\-\ palpable\\:\\ 0\\.021032090573609656\ \(0\)\
\-\ medical\\:\\ 0\\.018259095833791695\ \(0\)\
\-\ as\\:\\ 0\\.017952465359640662\ \(0\)\
\-\ no\\:\\ 0\\.017925919806329207\ \(0\)\
\-\ renal\\:\\ 0\\.017829691315681035\ \(0\)\
\-\ decreased\\:\\ 0\\.017644141685587218\ \(0\)\
\-\ s\\:\\ 0\\.017019219910517965\ \(0\)\
\-\ chronic\\:\\ 0\\.016715205784076387\ \(0\)\
\-\ lobe\\:\\ 0\\.015967537138357874\ \(0\)\
\-\ both\\:\\ 0\\.015154166601986954\ \(0\)\
\-\ increased\\:\\ 0\\.014517255429164275\ \(0\)\
\-\ other\\:\\ 0\\.013678045477100336\ \(0\)\
\-\ well\\:\\ 0\\.01342417328450452\ \(0\)\
\-\ 2\\:\\ 0\\.012778503447989904\ \(0\)\
\-\ surgical\\:\\ 0\\.012473762293412871\ \(0\)\
\-\ normal\\:\\ 0\\.009302864268049313\ \(0\)\
\-\ there\\:\\ 0\\.008831358031006865\ \(0\)\
\-\ history\\:\\ 0\\.008195934289632523\ \(0\)\
\-\ is\\:\\ 0\\.0078095941442323\ \(0\)\
\-\ the\\:\\ 0\\.006720451339759587\ \(0\)\
\-\ right\\:\\ 0\\.0062613313132667825\ \(0\)\
\-\ of\\:\\ 0\\.0032362166888330116\ \(0\)\
\-\ to\\:\\ 0\\.0029657507530762932\ \(0\)\
\-\ \\,\\:\\ 0\\.0018799310105367178\ \(0\)\
\-\ \\.\\:\\ 0\\.0017256718936209995\ \(0\)\
\-\ and\\:\\ 0\\.0012500625398070724\ \(0\)\
\-\ with\\:\\ 0\\.0008125290006242343\ \(0\)\
